NewCardio, Inc. (NWCI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Sep 12, 2025
NewCardio Market Cap
NewCardio has a market cap or net worth of $4.08 thousand as of October 8, 2025. Its market cap has decreased by -96.54% in one year.
Market Cap
4.08K
Enterprise Value
n/a
Revenue
238.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 4, 2008, NewCardio's market cap has decreased from 26.71M to 4.08K, a decrease of -99.98%. That is a compound annual growth rate of -39.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 4.08K | 9,853.66% |
| Dec 31, 2024 | 41.00 | -99.00% |
| Dec 15, 2023 | 4.08K | -96.67% |
| Dec 31, 2020 | 122.42K | 7.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 683.67M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |